JP2023521156A5 - - Google Patents
Info
- Publication number
- JP2023521156A5 JP2023521156A5 JP2022561665A JP2022561665A JP2023521156A5 JP 2023521156 A5 JP2023521156 A5 JP 2023521156A5 JP 2022561665 A JP2022561665 A JP 2022561665A JP 2022561665 A JP2022561665 A JP 2022561665A JP 2023521156 A5 JP2023521156 A5 JP 2023521156A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- sample
- proadm
- level
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024187993A JP2025022885A (ja) | 2020-04-06 | 2024-10-25 | 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20168321.6 | 2020-04-06 | ||
| EP20168321 | 2020-04-06 | ||
| EP20168591.4 | 2020-04-07 | ||
| EP20168591 | 2020-04-07 | ||
| EP20179787 | 2020-06-12 | ||
| EP20179787.5 | 2020-06-12 | ||
| EP20191084.1 | 2020-08-14 | ||
| EP20191084 | 2020-08-14 | ||
| PCT/EP2021/058885 WO2021204770A1 (en) | 2020-04-06 | 2021-04-06 | Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (sars) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024187993A Division JP2025022885A (ja) | 2020-04-06 | 2024-10-25 | 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521156A JP2023521156A (ja) | 2023-05-23 |
| JP2023521156A5 true JP2023521156A5 (https=) | 2023-09-13 |
| JP7579353B2 JP7579353B2 (ja) | 2024-11-07 |
Family
ID=75377819
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561665A Active JP7579353B2 (ja) | 2020-04-06 | 2021-04-06 | 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン |
| JP2024187993A Withdrawn JP2025022885A (ja) | 2020-04-06 | 2024-10-25 | 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024187993A Withdrawn JP2025022885A (ja) | 2020-04-06 | 2024-10-25 | 重症急性呼吸器症候群（ｓａｒｓ）における疾患進行を予後診断するためのプロアドレノメデュリン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230160893A1 (https=) |
| EP (1) | EP4133274A1 (https=) |
| JP (2) | JP7579353B2 (https=) |
| CN (1) | CN115803627A (https=) |
| AU (1) | AU2021251382B2 (https=) |
| BR (1) | BR112022017489A2 (https=) |
| CA (1) | CA3168893A1 (https=) |
| WO (1) | WO2021204770A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116525105B (zh) * | 2023-06-29 | 2023-10-03 | 中国人民解放军总医院 | 一种心源性休克预后预测预警系统、设备及可存储介质 |
| WO2025078420A1 (en) | 2023-10-09 | 2025-04-17 | B.R.A.H.M.S Gmbh | Biomarkers for therapy management and/or prognosing disease progression, severity and/or outcome for respiratory virus infections |
| WO2026013199A1 (en) | 2024-07-12 | 2026-01-15 | Cezanne S.A.S. | Clinical immunoassay with early signal measurement |
| CN120636758A (zh) * | 2025-05-21 | 2025-09-12 | 中国医学科学院北京协和医院 | 一种难治性肺炎支原体肺炎预测模型的构建方法、设备 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2570703B1 (fr) | 1984-09-26 | 1988-07-08 | Commissariat Energie Atomique | Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents |
| US4882733A (en) | 1987-03-13 | 1989-11-21 | Ford Aerospace Corporation | Method and apparatus for combining encoding and modulation |
| FR2664699B1 (fr) | 1990-07-13 | 1995-08-18 | Cis Bio Int | Procede d'amplification du signal d'emission d'un compose luminescent. |
| US9074236B2 (en) | 2012-05-01 | 2015-07-07 | Oxoid Limited | Apparatus and methods for microbial identification by mass spectrometry |
| WO2018060999A1 (en) * | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of risk assessment and disease classification |
| ES2944613T3 (es) * | 2017-02-02 | 2023-06-22 | Brahms Gmbh | proADM y/o histonas como marcadores indicadores de un acontecimiento adverso |
| EP3608673A1 (en) * | 2018-08-08 | 2020-02-12 | B.R.A.H.M.S GmbH | Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease |
-
2021
- 2021-04-06 WO PCT/EP2021/058885 patent/WO2021204770A1/en not_active Ceased
- 2021-04-06 JP JP2022561665A patent/JP7579353B2/ja active Active
- 2021-04-06 US US17/916,993 patent/US20230160893A1/en active Pending
- 2021-04-06 BR BR112022017489A patent/BR112022017489A2/pt unknown
- 2021-04-06 CA CA3168893A patent/CA3168893A1/en active Pending
- 2021-04-06 CN CN202180026965.6A patent/CN115803627A/zh active Pending
- 2021-04-06 EP EP21716433.4A patent/EP4133274A1/en active Pending
- 2021-04-06 AU AU2021251382A patent/AU2021251382B2/en active Active
-
2024
- 2024-10-25 JP JP2024187993A patent/JP2025022885A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023521156A5 (https=) | ||
| Dai et al. | Effect of artificial liver blood purification treatment on the survival of critical ill COVID‐19 patients | |
| Shah et al. | Mucormycosis as a complication of LONG COVID: A case series | |
| Zheng et al. | Analysis of the application value of serum antibody detection for staging of COVID‐19 infection | |
| JP2021534385A5 (https=) | ||
| JP2023041741A5 (https=) | ||
| Siddiqui et al. | Cotrimoxazole in the domiciliary management of patients with severe COVID-19: A case series | |
| Wang et al. | Neutrophil-to-lymphocyte ratio is a powerful predictor of adult patients with acute respiratory distress syndrome who might benefit from corticosteroid therapy | |
| JP2020533604A5 (https=) | ||
| CN112159867B (zh) | 一种2019新型冠状病毒微小rna及其在作为病毒感染诊断标志物中的应用 | |
| RU2408287C1 (ru) | Способ диагностики нарушения толерантности к глюкозе и сахарного диабета | |
| Yamada et al. | Multiple cardiovascular diseases or risk factors increase the severity of Coronavirus disease 2019 | |
| Poojitha et al. | Prevalence of comorbidities associated with COVID19 in andhra pradesh, India | |
| Tkachuk et al. | Respiratory symptoms of COVID-19 in an adolescent patient with WHIM syndrome: a clinical case | |
| Lu et al. | Predicting Bloodstream Infection in High-risk Groups of Liver Failure Patients with Artificial Liver Support System | |
| Rodriguez et al. | Genomic, Metagenomic and Transcriptomic Characterization of the Clinical Forms of COVID-19: A Comparative Cross-Sectional Study | |
| SU1388808A1 (ru) | Способ определени мукоцилиарной недостаточности у больных хроническими бронхолегочными заболевани ми | |
| Yuasa et al. | WCN24-295 COVID-19 AND ACUTE KIDNEY INJURY IN ELDERLY PATIENTS: COMPARATIVE COHORT STUDY BETWEEN THE FIRST AND SECOND WAVES OF THE PANDEMIC IN BRAZIL | |
| Phongphithakchai et al. | Effectiveness of HA330 hemoperfusion as an adjunctive therapy for severe COVID-19 patients: a single center experience | |
| RU2740587C9 (ru) | Способ ранней диагностики инсулинорезистентности у больных хронической обструктивной болезнью легких | |
| WO2024122680A1 (ko) | 급성 호흡 곤란 증후군 환자의 임상 징후 예측을 위한 정보 제공 방법 | |
| Abdullah et al. | Impact of hemodialysis on some biomarkers among patients with chronic kidney disease | |
| Molina-Infante et al. | Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy | |
| Song et al. | Clinical features in patients with acute pulmonary edema with confirmed coronavirus disease 2019 (COVID-19): comparison with those without acute pulmonary edema | |
| Wang et al. | Successful treatment of an 82‐year‐old COVID‐19 delta variant‐infected patient with haemorrhagic stroke and active prostate cancer brain metastasis |